NCT07227636 2026-02-06A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and ChemotherapyMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting284 enrolled
NCT04028063 2026-01-27Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue SarcomasUniversity of Colorado, DenverPhase 2 Recruiting65 enrolled
NCT06589440 2026-01-15Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Stingray TherapeuticsPhase 2 Recruiting70 enrolled
NCT05363709 2026-01-14BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer PatientsM.D. Anderson Cancer CenterPhase 2 Recruiting20 enrolled